Diabetes is associated with increased mortality rate in patients with COVID-19 and is considered as a major risk factor for COVID-19 infection, posing a major public health challenge for health policymakers in managing and controlling the disease. Therefore, development of prevention and treatment strategies aimed at reducing COVID-19 morbidity and mortality in diabetes patients is of significant importance.
Keyphrases
- public health
- type diabetes
- coronavirus disease
- sars cov
- cardiovascular disease
- end stage renal disease
- glycemic control
- newly diagnosed
- ejection fraction
- healthcare
- chronic kidney disease
- prognostic factors
- risk factors
- health information
- coronary artery disease
- insulin resistance
- risk assessment
- respiratory syndrome coronavirus
- metabolic syndrome